Skip to main navigation menu Skip to main content Skip to site footer

Current management of cervical microinvasive cancer: Hospital de San José

Manejo actual del cáncer microinvasor del cérvis: Hospital de San José




Section
Research Article

How to Cite
Mora, E., Ruiz Camero, H., Miranda, A., & Rodríguez, R. E. (2010). Current management of cervical microinvasive cancer: Hospital de San José. Journal of Medicine and Surgery Repertoire, 19(1), 35-40. https://doi.org/10.31260/RepertMedCir.v19.n1.2010.568

Dimensions
PlumX
license

   

Edmundo Mora
    Hernando Ruiz Camero
      Angel Miranda
        Rodrigo Ernesto Rodríguez

          In the world, cervical cancer ranks second in incidence after breast cancer and about three quarters of cases occur in developing countries. During the last two decades the incidence in the United States has decreased by almost a third thanks to the advent and application of screening programs. The association between cervical cancer and a causative agent transmitted in the sexual relationship called human papillomavirus has been established for a long time, which in the pathogenesis has a prevalence of HPV DNA in more than 90% of preinvasive lesions. invaders Cervical carcinoma is diagnosed in 21% of young women with active sexual life and who have not yet completed their desire for parity. This article reviews the current strategies in the management of patients with microinvasive carcinoma of the cervix and considers the mechanisms of therapeutic action. Abbreviations: HPV, human papillomavirus; NIC, intracervical neoplasia; LIE, intraepithelial lesion.


          Article visits 278 | PDF visits 3938


          Downloads

          Download data is not yet available.

          1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence. Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press; 2004.

          2. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Lyon: IARCPress, 2002 [IARC Scientific Publication No.155].

          3. Guías de práctica clínica en enfermedades neoplásicas. 2a ed. Bogotá: Instituto Nacional de Cancerología; 2001.

          4. Creasman WT. New gynecologic cancer staging. Gynecol Oncol. 1995; 58:157–8.

          5. Reich O, Pickel H, Tamussino K, Winter R. Microinvasive carcinoma of the cervix: site of first focus of invasion. Obstet Gynecol. 2001 Jun;97(6):890-2.

          6. Bekkers RL, Keyser KG, Bulten J, et al. The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. Int J Gynecol Cancer. 2002 Sep-Oct; 12(5):485-9.

          7. Paraskvaidis E, Kitchener HC, Kalantaridou SN, et al. Large loop conization for early invasive cervical cancer Int J. Gynecol Cancer. 1997; 7: 95-9.

          8. Raspagliesi F, Ditto A, et al. Prognostic factors in microinvasive cervical squamous cell cancer: long-term results. Int J Gynecol Cancer. 2005 Jan-Feb;15(1):88-93.

          9. Raspagliesi F, Ditto A, et al. Microinvasive squamous cell cervical carcinoma. Crit Rev Oncol Hematol. 2003 Dec;48(3):251-61.

          10. Abu-Rustum NR. Laparoscopy 2003: oncologic perspective. Clin Obstet Gynecol. 2003 Mar;46(1):61-9

          Sistema OJS 3.4.0.5 - Metabiblioteca |